Cheung, Bernard MY
Ng, Pauline Yeung
Liu, Ying
Zhou, Manman
Yu, Vincent
Yang, Julia
Wang, Natalie Q.
Funding for this research was provided by:
Pacira Pharmaceuticals
Nuance Biotech (Shanghai) Co., Ltd
Article History
Received: 8 January 2021
Accepted: 17 June 2021
First Online: 27 July 2021
Declarations
:
: Prior to screening, the study site obtained institutional review board approval from the Clinical Trials Centre of University of Hong Kong (The University of Hong Kong/Hospital Authority Hong Kong West Cluster IRB) that complied with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Good Clinical Practice and/or the Hong Kong Department of Health and respective research independent ethics committees/institutional review boards. All participants provided written informed consent before any study-specific screening procedures.
: Not applicable.
: BMYC has nothing to disclose. PYN has nothing to disclose. YL and MZ are employees of Nuance Biotech (Shanghai) Co., Ltd. VY is an employee of Pacira BioSciences, Inc., and may hold stock or stock options. JY and NQW are former employees of Pacira BioSciences, Inc.